Genetic and Immunologic Basis of COVID-19 Infection

NCT04384250 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-03-11

No results posted yet for this study

Summary

We will study genetic factors causing severe disease due to infection with SARS-COV-2 which may help to find targeted therapy

Conditions

  • Genetic Basis of COVID-19 Infection

Interventions

DIAGNOSTIC_TEST

Whole Exome Sequencing

Genetic study of patients

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2023-12-30
Completion
2024-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04384250 on ClinicalTrials.gov